Kymera Therapeutics outlines 2026 clinical trial plans

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/21/2026

1. WMT
2. ROST
3. AAP
4. NVDA
5. SPY
6. AVGO
7. SPCX
8. BJ
9. OSIS
10. QQQ

Go back to Kymera Therapeutics outlines 2026 clinical trial plans
(NASDAQ: KYMR) Delayed: 123.63 +2.13 (1.75%)
Previous Close $121.50    52 Week High $ 
Open $122.87    52 Week Low $ 
Day High $125.71    P/E N/A 
Day Low $121.34    EPS $ 
Volume 93,821